{"id":17543,"date":"2025-06-12T15:00:18","date_gmt":"2025-06-12T13:00:18","guid":{"rendered":"https:\/\/www.ifpma.org\/?post_type=news&#038;p=17543"},"modified":"2025-06-12T11:14:34","modified_gmt":"2025-06-12T09:14:34","slug":"pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security","status":"publish","type":"news","link":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/","title":{"rendered":"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security"},"content":{"rendered":"<p class=\"intro\">Geneva and Ottawa \u2013 Ahead of the upcoming G7 Leaders\u2019 Summit, the global pharmaceutical industry, represented by the <a href=\"https:\/\/www.ifpma.org\/\">International Federation of Pharmaceutical Manufacturers &amp; Associations<\/a> (IFPMA) and <a href=\"https:\/\/innovativemedicines.ca\/\">Innovative Medicines Canada<\/a> (IMC), are calling on G7 governments to place health and innovation at the top of their agenda at the upcoming leaders\u2019 summit.<\/p>\n<p>In an <a href=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7_Canada_Open_Letter_IMC_IFPMA_FINAL_EN.pdf\">open letter<\/a> published today, IFPMA and IMC, together with their members, have reaffirmed the industry\u2019s commitment to ongoing collaboration, including through Canada\u2019s G7 Presidency, to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.<\/p>\n<p>The <a href=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7_Canada_Open_Letter_IMC_IFPMA_FINAL_EN.pdf\">letter<\/a> calls on G7 leaders to recognize the strategic value of the innovative pharmaceutical industry by focusing discussions on three critical areas:<\/p>\n<ul>\n<li><strong>Investing in Healthcare as a Strategic Priority<\/strong>: Early adoption of medical innovation can transform health outcomes, increase healthcare system efficiency, and foster long-term socioeconomic growth. The G7 can lead in promoting innovation, particularly in tackling non-communicable diseases (NCDs), which are responsible for 75% of global deaths. With more than 9,600 medicines in development targeting NCDs and mental health, there is a clear opportunity for leadership.<\/li>\n<li><strong>Strengthening Global Health Security<\/strong>: The G7 has a vital role in advancing pandemic preparedness, addressing antimicrobial resistance (AMR), and reinforcing health systems. Industry investment in R&amp;D remains essential, and this requires an enabling policy environment\u2014one that upholds strong intellectual property protections, maintains open trade channels, and provides clear regulatory frameworks.<\/li>\n<li><strong>Harnessing the Pharmaceutical Industry as a Catalyst for Economic Growth and Resilience<\/strong>: The innovative pharmaceutical industry is an economic engine. In 2022, the industry contributed $2.3 trillion to global GDP, almost half of it from G7 economies, and supported nearly 75 million jobs worldwide. By championing health innovation, the G7 can unlock further economic potential while securing public health advancements.<\/li>\n<\/ul>\n<p>IFPMA and IMC emphasize that treating health as a long-term strategic priority must be a core component of the G7 agenda. This includes hosting a G7 Health Ministerial in 2025 to drive commitments and sustain momentum on key global health initiatives.<\/p>\n<p>\u201cHealth innovation is about more than medical breakthroughs\u2014it underpins both health and economic security,\u201d said Dr. David Reddy, Director General of IFPMA. \u201cWe\u2019re ready to work alongside G7 governments to keep health high on the global agenda and to ensure our industry can continue delivering the solutions needed to meet today\u2019s and tomorrow\u2019s challenges.\u201d<\/p>\n<p>\u201cCanada\u2019s G7 Presidency presents a timely opportunity to demonstrate global leadership in health innovation,\u201d said Bettina Hamelin, President of IMC. \u201cWe call on G7 leaders to recognize the pharmaceutical industry as a key partner in building resilient health systems, driving inclusive economic growth, and preparing for future health emergencies.\u201d<\/p>\n<p>Together, IFPMA and IMC reiterate their commitment to supporting G7 governments in advancing health-driven prosperity and stand ready to contribute meaningfully to discussions through the G7 Health Working Group and other key forums.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ahead of the G7 Leaders\u2019 Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry\u2019s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security. <\/p>\n","protected":false},"featured_media":17544,"template":"","news_type":[3],"topic":[20,77,76,12,15],"class_list":["post-17543","news","type-news","status-publish","has-post-thumbnail","hentry","news_type-press-release","topic-antimicrobial-resistance","topic-economic-growth-and-resilience","topic-global-health-security","topic-intellectual-property","topic-non-communicable-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security | IFPMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security | IFPMA\" \/>\n<meta property=\"og:description\" content=\"Ahead of the G7 Leaders\u2019 Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry\u2019s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/\" \/>\n<meta property=\"og:site_name\" content=\"IFPMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IFPMA\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png\" \/>\n\t<meta property=\"og:image:width\" content=\"932\" \/>\n\t<meta property=\"og:image:height\" content=\"643\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@IFPMA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/\",\"url\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/\",\"name\":\"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security | IFPMA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ifpma.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png\",\"datePublished\":\"2025-06-12T13:00:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#primaryimage\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png\",\"width\":932,\"height\":643},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ifpma.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.ifpma.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ifpma.org\/#website\",\"url\":\"https:\/\/www.ifpma.org\/\",\"name\":\"IFPMA\",\"description\":\"Innovating to improve health worldwide\",\"publisher\":{\"@id\":\"https:\/\/www.ifpma.org\/#organization\"},\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ifpma.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ifpma.org\/#organization\",\"name\":\"IFPMA\",\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"url\":\"https:\/\/www.ifpma.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"width\":1379,\"height\":733,\"caption\":\"IFPMA\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/IFPMA\/\",\"https:\/\/x.com\/IFPMA\",\"https:\/\/www.linkedin.com\/company\/ifpma\/\",\"https:\/\/www.youtube.com\/user\/ifpma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security | IFPMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/","og_locale":"en_US","og_type":"article","og_title":"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security | IFPMA","og_description":"Ahead of the G7 Leaders\u2019 Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry\u2019s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.","og_url":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/","og_site_name":"IFPMA","article_publisher":"https:\/\/www.facebook.com\/IFPMA\/","og_image":[{"width":932,"height":643,"url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@IFPMA","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/","url":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/","name":"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security | IFPMA","isPartOf":{"@id":"https:\/\/www.ifpma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#primaryimage"},"image":{"@id":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png","datePublished":"2025-06-12T13:00:18+00:00","breadcrumb":{"@id":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#primaryimage","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2025\/06\/G7-2025-Kananaskis-visual.png","width":932,"height":643},{"@type":"BreadcrumbList","@id":"https:\/\/www.ifpma.org\/news\/pharmaceutical-industry-calls-on-g7-to-prioritize-innovation-as-strategic-pillar-for-health-growth-and-security\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ifpma.org\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.ifpma.org\/news\/"},{"@type":"ListItem","position":3,"name":"Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security"}]},{"@type":"WebSite","@id":"https:\/\/www.ifpma.org\/#website","url":"https:\/\/www.ifpma.org\/","name":"IFPMA","description":"Innovating to improve health worldwide","publisher":{"@id":"https:\/\/www.ifpma.org\/#organization"},"alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ifpma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ifpma.org\/#organization","name":"IFPMA","alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","url":"https:\/\/www.ifpma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","width":1379,"height":733,"caption":"IFPMA"},"image":{"@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IFPMA\/","https:\/\/x.com\/IFPMA","https:\/\/www.linkedin.com\/company\/ifpma\/","https:\/\/www.youtube.com\/user\/ifpma"]}]}},"_links":{"self":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/news\/17543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media\/17544"}],"wp:attachment":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media?parent=17543"}],"wp:term":[{"taxonomy":"news_type","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/news_type?post=17543"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/topic?post=17543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}